Lichen Sclerosus
Lichen sclerosus (LS) is a chronic inflammatory skin condition that primarily affects the genital and anal areas. It causes white, patchy skin that is thinner than normal. In women, it commonly affects the vulva; in men, the foreskin and glans. LS can cause significant discomfort, scarring, and—if untreated—may increase the risk of squamous cell carcinoma.
Prevalence
Lichen sclerosus affects an estimated 1 in 300 to 1 in 1,000 people. It is more common in women and typically presents in two age peaks: prepubertal children and postmenopausal women.
Who It Affects
Women are affected 6-10 times more often than men. Most common in postmenopausal women, though it occurs at any age. Risk factors include autoimmune conditions, family history, and hormonal factors.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Topical Corticosteroids
High-potency topical steroids (clobetasol) are first-line treatment.
Limitations: Requires long-term maintenance. Side effects with prolonged use (skin thinning). Does not cure the condition.
Topical Calcineurin Inhibitors
Tacrolimus or pimecrolimus as alternatives or adjuncts to steroids.
Limitations: May cause burning initially. Black box warning (theoretical cancer risk, not proven in LS).
Emollients and Barrier Creams
Moisturizers to protect and soothe affected skin.
Limitations: Supportive but not disease-modifying.
Surgery
For scarring causing functional problems; circumcision in men with severe disease.
Limitations: Addresses complications but doesn't treat underlying condition. LS can recur.
Regular Monitoring
Important due to small increased risk of squamous cell carcinoma.
Limitations: Lifelong surveillance needed. Requires patient vigilance.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for lichen sclerosus is an emerging area exploring whether platelet-rich plasma (PRP) and other biologics can help with tissue healing and reduce inflammation. Some small studies have shown promise, but evidence remains limited.
Potential Benefits Being Studied:
- PRP may support tissue regeneration and healing
- May help reduce inflammation and itching
- Being studied as adjunct to standard treatment
- Some small studies showing symptom improvement
- May help with scarring and skin quality
- Does not replace topical steroid therapy
Biologics Used:
Platelet-rich plasma (PRP) in early clinical use
Exosomes being explored
Fat grafting with SVF in some cases
Frequently Asked Questions
Can regenerative therapy cure lichen sclerosus?
No therapy cures lichen sclerosus. It is a chronic condition requiring lifelong management. Regenerative approaches are being studied as potential adjuncts to improve symptoms and tissue quality.
Should I stop my steroid cream?
No. Topical corticosteroids are the proven first-line treatment and should be continued as directed. Regenerative therapies are being studied as additions to, not replacements for, standard care.
Is there good evidence for PRP in LS?
Evidence is early but some small studies are encouraging. Larger controlled trials are needed. It may be worth considering as part of a comprehensive treatment plan, but should not replace proven treatments.
Ready to Explore Your Options?
Schedule a free consultation to discuss lichen sclerosus and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for lichen sclerosus are investigational. Topical corticosteroids remain first-line treatment. LS requires ongoing monitoring due to cancer risk. Work with a dermatologist or gynecologist experienced in this condition.